NLS MedTech Business

Finnish eye care diagnostics company Revenio's iCare DRSplus fundus imaging system is now part of an FDA-cleared, AI-based diabetic retinopathy screening solution in the US. It is the first time the system has been included in such a solution.

The FDA has granted Premarket Approval (PMA) for RefluxStop, the company’s implant-based treatment for gastroesophageal reflux disease (GERD).

The U.S. Department of Veterans Affairs (VA) Strategic Acquisition Center has awarded a five-year national Non-Expendable Equipment (NX EQ) contract for quantitative neuromuscular monitoring to TrillaMed, LLC, the authorized U.S. federal distributor of the Senzime TetraGraph system.

XVIVO's heart preservation technology, XVIVO Heart Assist Transport system, has received CE certificates, making it available to any heart transplant center throughout Europe.

Medicover and the minority shareholders has entered an agreement to divest 100 per cent of equity in Medicover Hospitals India to funds managed by global investment firm KKR.

The new hub marks an investment in software development and clinical expertise and brings together these capabilities to accelerate the path to one intelligent digital ecosystem across the full perioperative workflow.